md-medicaldata

Authors

 

Maja Babić¹, Svetlana Anđelković<sup>2

1</sup>Zavod za zdravstvenu zaštitu radnika “Železnice Srbije” OJ Niš
²Zavod za zdravstvenu zaštitu radnika „Niš“

 

UDK: 616.24-008.4:616.8-009.836

The paper was received / Rad primljen: 01.10.2023.

Accepted / Rad prihvaćen: 21.10.2023.

 

Correspondence to:

Dr Maja Babić
Zavod za zdravstvenu zaštitu radnika “Železnice Srbije” OJ Niš
Dimitrija Tucovića 12
18000 Niš
e-mail: mbabic006@gmail.com

 

 

Sažetak

 

 

Sindrom opstruktivne apneje u spavanju je hronično progresivno oboljenje sa visokom incidencom i prevalencom u opštoj populaciji, koje bez adekvatne dijagnoze i terapije može dovesti do značajnih posledica po zdravlje i kvalitet života pacijenata. Opstruktivna apneja u snu (OSA) je veoma rasprostranjen poremećaj koji je brzo evoluirao u veliki globalni teret za javno zdravlje. Procenjuje se da je prevalenca OSA približno 25% kod odraslih muškaraca, 9-13% žena.  Najnoviji podaci potiču iz istraživanja sprovedenog 2019. godine i ukazuju da skoro milijardu ljudi uzrasta 30-70 godina u svetu trenutno boluje od neke forme opstruktivne sleep apnee, od čega preko 400 miliona ljudi (više od 45%) boluje od umerene do teške forme OSA koja zahteva ozbiljno lečenje. Smatra se da 80-90% pacijenata sa klinički značajnom OSA trenutno nije dijagnostikovano.
Postoji jasna korelacija između prisustva OSA i metaboličkih poremećaja, poput insulinske rezistencije, dijabetes melitusa i metaboličkog sindroma. OSA se često može naći i kod osoba obolelih od depresije, gastroezofagealnog refluksa i malignih oboljenja. Kao posledica ovih oštećenja, dolazi do problema u obavljanju svakodnevnih aktivnosti, uključujući i radne zadatke. Prisutan je pad radne sposobnosti, a sa druge strane, dolazi do povećanja rizika od povređivanja na radu i odsustvovanja sa posla. U našoj zemlji, nažalost, ova oblast još uvek nije regulisana na pravi način. Ne prepoznaje se opasnost koju mogu da izazovu ljudi koji imaju ovu bolest. Zato za nju kažemo da je tihi „ubica“, ali sa vrlo glasnim simptomima.
Veštačka inteligencija će biti osnova za pružanje jedinstvenog uvida u otkrivanju pacijenata sa OSA gde će dijagnostički i terapijski putevi biće potpuno preoblikovani novim automatizovanim metodama i veštačkom inteligencijom.

 

Ključne reči:

Sleep apnea, zdravlje, radna sposobnost

 

 

 

Abstract

 

Obstructive sleep apnea syndrome is a chronic progressive disease with a high incidence and prevalence in the general population, which without adequate diagnosis and therapy can lead to significant consequences for the health and quality of life of patients. Obstructive sleep apnea (OSA) is a highly prevalent disorder that has rapidly evolved into a major global public health burden. It is estimated that the prevalence of OSA is approximately 25% in adult men, 9-13% in women. The latest data comes from research conducted in 2019 and indicates that almost one billion people aged 30-70 worldwide currently suffer from some form of obstructive sleep apnea, of which over 400 million people (more than 45%) suffer from a moderate to severe form of OSA which requires serious treatment. It is thought that 80-90% of patients with clinically significant OSA are currently undiagnosed.
There is a clear correlation between the presence of OSA and metabolic disorders, such as insulin resistance, diabetes mellitus and metabolic syndrome. OSA can often be found in people suffering from depression, gastroesophageal reflux and malignant diseases. As a consequence of these damages, there are problems in performing daily activities, including work tasks. There is a decrease in work ability, and on the other hand, there is an increase in the risk of injury at work and absence from work. In our country, unfortunately, this area is still not properly regulated. The danger that can be caused by people who have this disease is not recognized. That's why we call it a silent "killer", but with very loud symptoms.
Artificial intelligence will be the basis for providing unique insight into the detection of patients with OSA where diagnostic and therapeutic pathways will be completely reshaped by new automated methods and artificial intelligence.

 

Key words:

Sleep apnea, health, working abillity

 

 

 

 

References:

1. Lévy P, Kohler M, McNicholas WT, et al. Obstructive sleep apnoea syndrome. Nat Rev Dis Primers 2015; 1:15015. doi: 10.1038/nrdp.2015.15.
2. Benjafield AV, Ayas NT, Eastwood PR, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med 2019;7(8):687-698. doi: 10.1016/S2213-2600(19)30198-5.
3. Kales A, Vela-Bueno A, Kales JD. Sleep disorders: sleep apnea and narcolepsy. Ann Intern Med. 1987;106(3):434-43. doi: 10.7326/0003-4819-106-3-434.
4. Webb P. Periodic breathing during sleep. J Appl Physiol. 1974;37(6):899-903. doi: 10.1152/jappl.1974.37.6.899.
5. Plum F, Leigh RJ. Abnormalities of central mechanisms. In : Hornbein TF ed. Regulation of breathing, part II, New York:Marcel Dekker. 1981.
6. Koo DL, Nam H, Thomas RJ, Yun CH. Sleep Disturbances as a Risk Factor for Stroke. J Stroke. 2018;20(1):12-32. doi: 10.5853/jos.2017.02887.
7. Simon RP. Breathing and the nervous system. In: Aminof MJ, Ed. Neurology and general medicine. New York: Churcill Livingstone,1993.
8. Popević MB, Milovanović A, Nagorni-Obradović L, Nešić D, Milovanović J, Milovanović APS. Screening commercial drivers for obstructive sleep apnea: translation and validation of Serbian version of Berlin Questionnaire. Qual Life Res. 2016 Feb;25(2):343-349. doi: 10.1007/s11136-015-1087-3.
9. Karimi M, Hedner J, Lombardi C, Mcnicholas WT, Penzel T, Riha RL, Rodenstein D, Grote L; Esada Study Group. Driving habits and risk factors for traffic accidents among sleep apnea patients--a European multi-centre cohort study. J Sleep Res. 2014(6):689-699. doi: 10.1111/jsr.12171.
10. Commission Directive 2014/85/EU, July 1st, 2014, on Driving licenses. Official J Eur Union.L194/10,2014.
11. Gurubhagavatula I, Sullivan S, Meoli A, Patil S, Olson R, Berneking M, Watson NF. Management of Obstructive Sleep Apnea in Commercial Motor Vehicle Operators: Recommendations of the AASM Sleep and Transportation Safety Awareness Task Force. J Clin Sleep Med. 2017;13(5):745-758. doi: 10.5664/jcsm.6598.
12. Gagnadoux F, Pelletier-Fleury N, Philippe C, et al. Home unattended versus hospital telemonitored polysomnography in suspected obstructive sleep apnea syndrome: a randomized crossover trial. Chest 2002 ;121(3):753-8. doi: 10.1378/chest.121.3.753.
13. Shiomi T. [Telemedicine and lifestyle modifications in obstructive sleep apnea patients]. Nihon Rinsho 2000;58(8):1689-92.
14. Spaulding R, Stevens D, Velasquez SE. Experience with telehealth for sleep monitoring and sleep laboratory management. J Telemed Telecare 2011;17(7):346e9. https://doi.org/10.1258/jtt.2011.110202.
15. Böhning N, Zucchini W, Hörstmeier O, Böhning W, Fietze I. Sensitivity and specificity of telemedicine-based long-term pulse-oximetry in comparison with cardiorespiratory polygraphy and polysomnography in patients with obstructive sleep apnoea syndrome. J Telemed Telecare. 2011;17(1):15-9. doi: 10.1258/jtt.2010.100205.
    

PDF: 07-Babić M. and Anđelković S. MD-Medical Data 2023;15(3) 101-104.pdf